The Scleroderma Biorepository and Pathogenesis Study (STOP Scleroderma)

George Washington University (GW)

Status: Completed

Conditions: Scleroderma

Study type: Observational

Funder types: Other

Identifiers

NCT02887495

051427

Details and patient eligibility

About

The Scleroderma bioreposiTOry and Pathogenesis Study (STOP Scleroderma) will help researchers use clinical data and human biospecimens to investigate why scleroderma patients develop certain complications from their disease. Patients with confirmed scleroderma, raynauds or positive autoantibodies are invited to participate. This research may help us understand how to prevent and treat scleroderma and other diseases.

Enrollment: 600 estimated patients

Sex: All

Ages: 18 to 100 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age >18 years
• Able to give informed consent.
• Diagnosed with scleroderma or with positive autoantibodies

Exclusion criteria

• < 18 years old